Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Müge Sak

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|September 13, 2025
Systematic Analysis of Alternative Splicing in Transcriptomes of Multiple Sclerosis Patient Brain SamplesMüge Sak, Julia H Chariker, Eric C Rouchka
International Journal of Molecular Sciences|November 27, 2024
Gene Expression and Alternative Splicing Analysis in a Large-Scale Multiple Sclerosis StudyMüge Sak, Julia H Chariker, Juw Won Park, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2024
Gene expression and alternative splicing analysis in a large-scale Multiple Sclerosis studyMüge Sak, Julia H Chariker, Juw Won Park, et al.
Free Neuropathology|June 7, 2023
Malignant melanotic nerve sheath tumor with PRKAR1A, KMT2C, and GNAQ mutationsMerryl Terry, Kristina Wakeman, Brian J Williams, et al.
Frontiers in Cellular Neuroscience|May 8, 2025
<i>O</i> <sup>6</sup>-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances <i>in vitro</i> clonogenicity, tumor implantation <i>in vivo</i>, and <i>sensitivity</i> to alisertib-carboplatin combination treatmentMüge Sak, Brian J Williams, Andrew J Hey, et al.
Frontiers in Cellular Neuroscience|July 9, 2025
Corrigendum: <i>O</i> <sup>6</sup>-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances <i>in vitro</i> clonogenicity, tumor implantation <i>in vivo</i>, and <i>sensitivity</i> to alisertib-carboplatin combination treatmentMüge Sak, Brian J Williams, Andrew J Hey, et al.
Diagnostic Pathology|October 28, 2021
Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasmsKhaled J Alkhateeb, Jason E Crane, Müge Sak, et al.
Cancer Chemotherapy and Pharmacology|January 24, 2023
The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivoMüge Sak, Brian J Williams, Cory T Zumbar, et al.
Journal of Neuro-Oncology|April 24, 2019
Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cellsMüge Sak, Cory T Zumbar, Paul D King, et al.
Nature Communications|April 20, 2022
Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genesNorman L Lehman, Nathalie Spassky, Müge Sak, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|September 13, 2025
Systematic Analysis of Alternative Splicing in Transcriptomes of Multiple Sclerosis Patient Brain SamplesMüge Sak, Julia H Chariker, Eric C Rouchka
International Journal of Molecular Sciences|November 27, 2024
Gene Expression and Alternative Splicing Analysis in a Large-Scale Multiple Sclerosis StudyMüge Sak, Julia H Chariker, Juw Won Park, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2024
Gene expression and alternative splicing analysis in a large-scale Multiple Sclerosis studyMüge Sak, Julia H Chariker, Juw Won Park, et al.
Free Neuropathology|June 7, 2023
Malignant melanotic nerve sheath tumor with PRKAR1A, KMT2C, and GNAQ mutationsMerryl Terry, Kristina Wakeman, Brian J Williams, et al.
Frontiers in Cellular Neuroscience|May 8, 2025
<i>O</i> <sup>6</sup>-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances <i>in vitro</i> clonogenicity, tumor implantation <i>in vivo</i>, and <i>sensitivity</i> to alisertib-carboplatin combination treatmentMüge Sak, Brian J Williams, Andrew J Hey, et al.
Frontiers in Cellular Neuroscience|July 9, 2025
Corrigendum: <i>O</i> <sup>6</sup>-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances <i>in vitro</i> clonogenicity, tumor implantation <i>in vivo</i>, and <i>sensitivity</i> to alisertib-carboplatin combination treatmentMüge Sak, Brian J Williams, Andrew J Hey, et al.
Diagnostic Pathology|October 28, 2021
Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasmsKhaled J Alkhateeb, Jason E Crane, Müge Sak, et al.
Cancer Chemotherapy and Pharmacology|January 24, 2023
The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivoMüge Sak, Brian J Williams, Cory T Zumbar, et al.
Journal of Neuro-Oncology|April 24, 2019
Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cellsMüge Sak, Cory T Zumbar, Paul D King, et al.
Nature Communications|April 20, 2022
Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genesNorman L Lehman, Nathalie Spassky, Müge Sak, et al.
Pageof 2